Ballicules.com

Metoclopramide and Pramipexole: a Dopamine D2 receptor interaction

Metoclopramide blocks the dopamine D2 receptor, so Pramipexole cannot act there — the effect of Pramipexole is reduced or lost.

Pramipexole is an agonist at the dopamine D2 receptor: it binds and switches the receptor on. Metoclopramide is an antagonist at the same site and switches nothing on. With both present they compete for the same pocket, and whichever is there in greater effective concentration decides what the receptor does.

Given together they work against whatever each was started for. If both are genuinely needed, expect less of Pramipexole’s effect than its dose would suggest.

This is a pharmacodynamic interaction. Neither drug changes the other’s concentration, so a level, an AUC estimate or a genotype looks entirely normal while the clinical effect is blunted.

The direction can be the useful one. The same opposition is what makes a reversal agent, an antidote or a planned antagonist work.

Metoclopramide versus Pramipexole over the Dopamine D2 receptor
Fight club: Metoclopramide versus Pramipexole — Dopamine D2 receptor

The two ballicules, with the Dopamine D2 receptor lit on each

Metoclopramide ballicule, with its Dopamine D2 receptor peg ringed
Metoclopramide (REGLAN)
Dopamine D2 receptor antagonist
Pramipexole ballicule, with its Dopamine D2 receptor peg ringed
Pramipexole (MIRAPEX)
Dopamine D2 receptor agonist

The ring marks the peg each drug wears for this receptor — the same cross-illumination Interact! draws when the two are put side by side.

The mascots

Metoclopramide mascot mnemonic cartoon
Metoclopramide
Ronald Reglan Met a clopper
Pramipexole mascot mnemonic cartoon
Pramipexole
Pray my pecs, ol’ Mirror pecs

Open it in the console